Amorphous form of apremilast
US9351957B2 · kind B2 · utility
2Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2015 |
| Grant date | May 31, 2016 |
| Priority date | — |
| Expiry date | Apr 2, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an amorphous form of apremilast and process for preparation thereof. The present invention also provides a pharmaceutical composition comprising an amorphous apremilast and one or more of pharmaceutically acceptable carriers, excipients or diluents used for the treatment of active psoriatic arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.